Aug 17, 2021 / 08:00AM GMT
Operator
Ladies and gentlemen, welcome to BerGenBio conference call for the first half of 2021. I will now hand the word over to the speakers. Please go ahead.
Richard Godfrey - BerGenBio ASA - CEO
Thank you, and good morning. This is Richard Godfrey, CEO of BerGenBio. Welcome to our half 1 quarter 2 report and highlights and financials for 2021. I'm joined this morning by Rune Skeie, our CFO. Next slide, please.
Firstly, may I draw your attention to our forward-looking statements and the safe harbor comments. As we are a publicly-traded company, it's important that these are beared in mind. Thank you. Next slide, please.
Here is a schedule of some of the topics I'd like to cover during this morning's presentation. Next slide, please.
On Slide 4, I thought I'd provide a brief snapshot of the first half of 2021 and quarter 2. I guess it's important when reviewing our company's performance to remember that we're still coming out of, or indeed arguably still in, the pandemic of COVID-19. And although our company, as many have made operational
Q2 2021 Bergenbio ASA Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
